Skip to content
Disclosery

VHCP Management, LLC

Follow

13F filer, CIK 1479355, NEW YORK, NY

VHCP Management, LLC reported $354,492,000 across 18 holdings for the quarter ended 2015-06-30, in a 13F-HR filed 2015-08-13. Its ten largest share positions make up 85.92% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-15-008947

Period
2015-06-30
Reported value
$354M
Holdings
18
Top 10 weight
85.92%
New
1
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ARCA biopharma Incnew+10,789,324$12.4M
LIPOCINE INC NEWadded+600,000$5.15M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
JUNO THERAPEUTICS INCreduced-1,659,793-$88.5M
Cynapsus Therapeutics Increduced-5,511,428-$88.4M
BCRXreduced-1,370,670-$20.5M
DYAX CORPexited-1,000,659-$16.8M
THERAPEUTICSMD INCexited-846,500-$5.12M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2015

Share positions as resolved from 13F-HR 0000950123-15-008947, largest first. % of portfolio is the value over $354,492,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ANACOR PHARMACEUTICALS INCANACOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,178,474 shares; 2015Q2: 1,178,474 shares 1,178,474$91.2M25.74%0
GW PHARMACEUTICALS PLCGW PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 311,853 shares; 2015Q2: 311,853 shares 311,853$38.3M10.81%0
DBV TechnologiesDBV TechnologiesQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 693,810 shares; 2015Q2: 693,810 shares 693,810$37.1M10.48%0
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,095,734 shares; 2015Q2: 1,095,734 shares 1,095,734$34.1M9.63%0Timeline
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 870,269 shares; 2015Q2: 870,269 shares 870,269$25.2M7.09%0Timeline
AVALANCHE BIOTAVALANCHE BIOTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,382,735 shares; 2015Q2: 1,382,735 shares 1,382,735$22.5M6.33%0
ZAFGEN INCZAFGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 541,480 shares; 2015Q2: 541,480 shares 541,480$18.8M5.29%0
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 811,152 shares; 2015Q2: 811,152 shares 811,152$14.1M3.97%0Timeline
ARCA biopharma IncARCA biopharma IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: 10,789,324 shares 10,789,324$12.4M3.5%new
LIPOCINE INC NEWLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 669,921 shares; 2015Q2: 1,269,921 shares 1,269,921$10.9M3.07%+600,000
FLAMEL TECHNOLOGIES-SP ADRFLAMEL TECHNOLOGIES-SP ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 500,000 shares; 2015Q2: 500,000 shares 500,000$10.6M2.99%0
Alcobra LtdAlcobra LtdQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,500,000 shares; 2015Q2: 1,500,000 shares 1,500,000$9.81M2.77%0
Cynapsus Therapeutics IncCynapsus Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 5,878,855 shares; 2015Q2: 367,427 shares 367,427$5.89M1.66%-5,511,428
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,744,356 shares; 2015Q2: 373,686 shares 373,686$5.58M1.57%-1,370,670Timeline
STEMLINE THERAPEUTICS INCSTEMLINE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 451,400 shares; 2015Q2: 451,400 shares 451,400$5.31M1.5%0
ZS PHARMA INCZS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 100,000 shares; 2015Q2: 100,000 shares 100,000$5.24M1.48%0
JUNO THERAPEUTICS INCJUNO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,749,999 shares; 2015Q2: 90,206 shares 90,206$4.81M1.36%-1,659,793
OCERA THERAPEUTICS INC COMOCERA THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 703,730 shares; 2015Q2: 703,730 shares 703,730$2.67M0.75%0

Sold out in Q2 2015

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DYAX CORPDYAX CORP1,000,659$16.8Mshares
THERAPEUTICSMD INCTHERAPEUTICSMD INC846,500$5.12Mshares

How Q2 2015 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-15-008947 base2015-08-13acceptance time not in the bulk data set